Psychiatric Care Via Videoconferencing
- Conditions
- Depression
- Interventions
- Procedure: Online consultationProcedure: Face-to-face consultation
- Registration Number
- NCT01901315
- Lead Sponsor
- University of Sao Paulo General Hospital
- Brief Summary
The purpose of this project is to compare the effectiveness between face-to-face consultations and consultations via videoconferencing among patients treated in the Institute of Psychiatry (IPq).
- Detailed Description
Introduction: Within the emergence of the Internet and for the purposes of providing psychiatric services across distances, the provision of mental health service via video counseling has become a possible way of mental health service delivery. An appropriate systematization of the propaedeutic methods in psychiatry, according to the interactive resources of telemedicine, and a standardized assessment based on clinical records turn this method to a viable alternative for service delivery all over the world. The main benefit of video counseling is an increased access to care services. But, so far, there is still limited research regarding to the effectiveness of telepsychiatry in the management of mental illnesses.
Objective: To verify the applicability of psychiatric attendance via Interned-based videoconferencing, comparing various quality characteristics between this method and face-to-face attendance, on the basis of a one-year follow-up study with a randomized clinical trial (RCT) design.
Material and methods: 100 patients of the Institute of Psychiatry (IPq) between 18 to 55 years old with depressive disorders are randomly allocated to a control (monthly face-to-face consultation with the attending psychiatrist) or intervention group. The intervention group will have consultations with the attending psychiatrist through internet-based videoconference. For reasons of patient safety, consultations at baseline, and after 6 and 12 months will be realized in a face-to-face form for all patients. At baseline, and after 6 and 12 months mental health, satisfaction with treatment, therapeutic relationship, and medical compliance will be assessed. Depression will be assessed at baseline, and after 3, 6, 9 and 12 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 107
- depressive disorder
- between 18 to 55 years
- broadband Internet access
- Hamilton Depression Rating Scale total score > 15
- severe cognitive limitations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Online consultation Online consultation Monthly video consultations with psychiatrist Face-to-face consultation Face-to-face consultation Monthly face-to-face consultations with psychiatrist
- Primary Outcome Measures
Name Time Method Baseline Depression Severity 0 months (baseline) Instrument: Hamilton Depression Rating Scale
Change from Baseline in Depression Severity at 6 months 6 months Instrument: Hamilton Depression Rating Scale
Change from Baseline and 6-months Follow-up in Depression Severity at 12 months 12 months Instrument: Hamilton Depression Rating Scale
Baseline Satisfaction with Treatment 0 months (baseline) Instrument: Client Satisfaction Questionnaire (CSQ-8)
Change from Baseline in Satisfaction with Treatment at 6 months 6 months Instrument: Client Satisfaction Questionnaire (CSQ-8)
Change from Baseline and 6-months Follow-up in Satisfaction with Treatment at 12 months 12 months Instrument: Client Satisfaction Questionnaire (CSQ-8)
Baseline Mental Health 0 months (baseline) Instrument: Mental Health Inventory (MHI)
Change from Baseline in Mental Health at 6 months 6 months Instrument: Mental Health Inventory (MHI)
Change from Baseline and 6-months Follow-up in Mental Health at 12 months 12 months Instrument: Mental Health Inventory (MHI)
Baseline Quality of Therapeutic Relationship 0 months (baseline) Instrument: Working Alliance Inventory (WAI)
Change from Baseline in Quality of Therapeutic Relationship at 6 months 6 months Instrument: Working Alliance Inventory (WAI)
Change from Baseline in Medical Adherence at 6 months 6 months Instrument: self-reported measure of medication adherence with four items:
* Do you forget to take your medication?
* Are you careless at times about taking your medicine?
* When you feel better, do you sometimes stop taking your medicine?
* Sometimes when you feel worse, do you stop taking your medicine?
Response categories are yes/no for each item with a dichotomous response and a 5-point Likert response for the last item.Change from Baseline and 6-months Follow-up in Medical Adherence at 12 months 12 months Instrument: self-reported measure of medication adherence with four items:
* Do you forget to take your medication?
* Are you careless at times about taking your medicine?
* When you feel better, do you sometimes stop taking your medicine?
* Sometimes when you feel worse, do you stop taking your medicine?
Response categories are yes/no for each item with a dichotomous response and a 5-point Likert response for the last item.Change from Baseline and 6-months Follow-up in Quality of Therapeutic Relationship at 12 months 12 months Instrument: Working Alliance Inventory (WAI)
Baseline Medical Adherence 0 months (baseline) Instrument: self-reported measure of medication adherence with four items:
* Do you forget to take your medication?
* Are you careless at times about taking your medicine?
* When you feel better, do you sometimes stop taking your medicine?
* Sometimes when you feel worse, do you stop taking your medicine?
Response categories are yes/no for each item with a dichotomous response and a 5-point Likert response for the last item.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institute of Psychiatry, School of Medicine, University of Sao Paulo
🇧🇷Sao Paulo, Brazil